313 related articles for article (PubMed ID: 20061248)
1. Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours.
Pfohl-Leszkowicz A
Arh Hig Rada Toksikol; 2009 Dec; 60(4):465-83. PubMed ID: 20061248
[TBL] [Abstract][Full Text] [Related]
2. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor.
Pfohl-Leszkowicz A; Tozlovanu M; Manderville R; Peraica M; Castegnaro M; Stefanovic V
Mol Nutr Food Res; 2007 Sep; 51(9):1131-46. PubMed ID: 17729220
[TBL] [Abstract][Full Text] [Related]
3. Mycotoxic and aristolochic acid theories of the development of endemic nephropathy.
Peraica M; Domijan AM; Sarić M
Arh Hig Rada Toksikol; 2008 Mar; 59(1):59-65. PubMed ID: 18407872
[TBL] [Abstract][Full Text] [Related]
4. Ochratoxin A in human kidney diseases.
Fuchs R; Peraica M
Food Addit Contam; 2005; 22 Suppl 1():53-7. PubMed ID: 16332622
[TBL] [Abstract][Full Text] [Related]
5. Balkan endemic nephropathy: an update on its aetiology.
Stiborová M; Arlt VM; Schmeiser HH
Arch Toxicol; 2016 Nov; 90(11):2595-2615. PubMed ID: 27538407
[TBL] [Abstract][Full Text] [Related]
6. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy.
Arlt VM; Pfohl-Leszkowicz A; Cosyns J; Schmeiser HH
Mutat Res; 2001 Jul; 494(1-2):143-50. PubMed ID: 11423353
[TBL] [Abstract][Full Text] [Related]
7. The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats.
Stiborová M; Bárta F; Levová K; Hodek P; Frei E; Arlt VM; Schmeiser HH
Arch Toxicol; 2015 Nov; 89(11):2141-58. PubMed ID: 25209566
[TBL] [Abstract][Full Text] [Related]
8. Balkan endemic nephropathy: role of ochratoxins A through biomarkers.
Castegnaro M; Canadas D; Vrabcheva T; Petkova-Bocharova T; Chernozemsky IN; Pfohl-Leszkowicz A
Mol Nutr Food Res; 2006 May; 50(6):519-29. PubMed ID: 16715544
[TBL] [Abstract][Full Text] [Related]
9. Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy.
De Broe ME
Kidney Int; 2012 Mar; 81(6):513-5. PubMed ID: 22373701
[TBL] [Abstract][Full Text] [Related]
10. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.
Stiborova M; Frei E; Arlt VM; Schmeiser HH
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):5-11. PubMed ID: 19365519
[TBL] [Abstract][Full Text] [Related]
11. Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer.
Arlt VM; Stiborová M; vom Brocke J; Simões ML; Lord GM; Nortier JL; Hollstein M; Phillips DH; Schmeiser HH
Carcinogenesis; 2007 Nov; 28(11):2253-61. PubMed ID: 17434925
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review.
Gökmen MR; Cosyns JP; Arlt VM; Stiborová M; Phillips DH; Schmeiser HH; Simmonds MS; Cook HT; Vanherweghem JL; Nortier JL; Lord GM
Ann Intern Med; 2013 Mar; 158(6):469-77. PubMed ID: 23552405
[TBL] [Abstract][Full Text] [Related]
13. Effects of Diet on Aristolochic Acid-DNA Adduct Formation: Implications for Balkan Endemic Nephropathy Etiology.
Zhang J; Chan CK; Pavlović NM; Chan W
Chem Res Toxicol; 2023 Mar; 36(3):438-445. PubMed ID: 36881864
[TBL] [Abstract][Full Text] [Related]
14. Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary tract tumours in Bulgaria.
Petkova-Bocharova T; Castegnaro M
IARC Sci Publ; 1991; (115):135-7. PubMed ID: 1820326
[TBL] [Abstract][Full Text] [Related]
15. DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer.
Stiborová M; Arlt VM; Schmeiser HH
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036902
[TBL] [Abstract][Full Text] [Related]
16. Ochratoxin A and other mycotoxins in cereals from an area of Balkan endemic nephropathy and urinary tract tumours in Bulgaria.
Petkova-Bocharova T; Castegnaro M; Michelon J; Maru V
IARC Sci Publ; 1991; (115):83-7. PubMed ID: 1820357
[TBL] [Abstract][Full Text] [Related]
17. Aristolochic acid and its effect on different cancers in uro-oncology.
Rebhan K; Ertl IE; Shariat SF; Grollman AP; Rosenquist T
Curr Opin Urol; 2020 Sep; 30(5):689-695. PubMed ID: 32701724
[TBL] [Abstract][Full Text] [Related]
18. The involvement of mycotoxins in the development of endemic nephropathy.
Peraica M; Domijan AM; Miletić-Medved M; Fuchs R
Wien Klin Wochenschr; 2008; 120(13-14):402-7. PubMed ID: 18726664
[TBL] [Abstract][Full Text] [Related]
19. Ochratoxin A as a potential etiologic factor in endemic nephropathy: lessons from toxicity studies in rats.
Mally A; Hard GC; Dekant W
Food Chem Toxicol; 2007 Nov; 45(11):2254-60. PubMed ID: 17629386
[TBL] [Abstract][Full Text] [Related]
20. Role of exposure analysis in solving the mystery of Balkan endemic nephropathy.
Long DT; Voice TC
Croat Med J; 2007 Jun; 48(3):300-11. PubMed ID: 17589972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
